CrystalGenomics Invites Co., LTD. (KOSDAQ:A083790) agreed to acquire an 89.95% stake in PROCAGEN from Invites Biocore Co., Ltd. (XKON:A216400) and others for KRW 13.1 billion on December 28, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,400 KRW | -2.63% |
|
-2.50% | -20.43% |
1st Jan change | Capi. | |
---|---|---|
-20.43% | 41.31M | |
-43.34% | 7.74B | |
+10.68% | 3.66B | |
-1.60% | 2.24B | |
-22.96% | 1.94B | |
-22.17% | 1.64B | |
+5.19% | 915M | |
+17.25% | 734M | |
-6.99% | 711M | |
-37.14% | 454M |
- Stock Market
- Equities
- A216400 Stock
- News Invites Biocore Co., Ltd.
- CrystalGenomics Invites Co., LTD. agreed to acquire an 89.95% stake in PROCAGEN from Invites Biocore Co., Ltd. and others for KRW 13.1 billion